PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for July 2, 2008 Subscribe to this News Feed    
 

New MagnaBloc™ Product Available from Gradient Medical

Gradient Medical recently started offering QuadraBloc™, a new and improved version of AmWay's MagnaBloc.

Memphis, TN (PRWEB) July 2, 2008 -- AmWay's MagnaBloc™, a long-popular form of pain management, is now available in a new, stronger form: QuadraBloc™, offered by Gradient Medical.

"QuadraBloc has already been released in the United States, and will be available worldwide within 60 sixty days," said John Townsend, President of Gradient Medical, LLC. "We will also be releasing several new products within the next few weeks."

QuadraBloc has already been released in the United States, and will be available worldwide within 60 sixty days
Put simply, the QuadraBloc uses magnetic principles to disrupt the transduction of the electrochemical pain signals to the brain. QuadraBloc uses not one but four magnets and a focusing ring placed in a square or diamond pattern. For maximum pain management the QuadraBloc is placed directly over the irritated nerve, where the gradient of the magnetic field has the strongest impact on the nerve's pain signal.

"QuadraBloc is between two and four times stronger than MagnaBloc," Townsend said. "This technology offers an alternative for superior pain relief for people with back pain, sports injuries, and other sources of chronic pain."

The principles that the QuadraBloc is based on were first published in Environmental Science in 1991. In addition, the device's effectiveness is supported by more than a decade of cell research at the Vanderbilt University School of Medicine and at the Center for Pain Research and Neuromagnetics at the University Medical Center in Nashville, Tennessee, as well as numerous other studies performed around the world. To eliminate the experimenters' biases, several of the studies done have been "double blinded," which is where neither the doctor nor the patient know which group the patient is in: the experimental group, which uses the QuadraBloc device, or the control group, which uses a "placebo" or a dummy device.

"The principles used in creating the QuadraBloc have been scientifically researched and well documented," Townsend said. "All of the results to date demonstrate that QuadraBlocs are safe, low in cost and remarkably effective in treating a large variety of aches and pains."

Townsend indicated that the product has not been approved by FDA, has been sold as an OTC product in 40 countries including the US and is not intended to obviate the need to seek professional assistance for health care professionals.

For more information about Gradient Medical and the QuadraBloc™, including laboratory results, videos, and testimonials, please visit www.QuadraBloc.com.

About Gradient Medical, LLC:
The owner of multiple patents for the design and use of QuadraBlocs, Gradient Medical, LLC is a pioneer in the field of using magnets for health. After AmWay's 10-year license of MagnaBloc expired in April of 2008, Gradient Medical launched the QuadraBloc, which offers non surgical and non drug alternatives for the management of pain. For more information about Gradient Medical's products, including the QuadraBloc, please visit http://www.QuadraBloc.com.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1GYWx1LUhhbGYtSGFsZi1FbXB0LVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
John Townsend
Gradient Medical
901-767-2384
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Close Move